WuXi Biologics Honored with 2025 Global Customer Value Leadership Recognition by Frost & Sullivan
SHANGHAI, Oct. 20, 2025 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has been honored with the Frost & Sullivan’s 2025 Global Customer …